Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Ramirez: Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. (0.11 sec) 

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control


LC Ramirez, C Arauz-Pacheco, C Lackner, … - Annals of internal …, 1992 - Am Coll Physicians
Design: A cross-sectional study. Comparisons of lipoprotein (a) concentrations were made between
a normal control group, a group of diabetic patients with glycated hemoglobin (HbA 1c ) less
than 8.0%, and a group of diabetic patients with HbA 1c of 8.0% or higher.
Cited by 68 - Related articles - All 3 versions

Lipoprotein (a) levels in black and white children and adolescents with IDDM


LL Levitsky, AM Scanu, SH Gould - Diabetes Care, 1991 - Am Diabetes Assoc
OBJECTIVE: To examine the relationship between levels of lipoprotein(a) [Lp(a)], diabetes, and
glycemic control in white and black nondiabetic control and insulin-dependent diabetic
(IDDM) children and adolescents, fasting blood analyses were conducted on a subject ...
Cited by 81 - Related articles - All 7 versions

Serum lipoprotein (a) in patients with diabetes mellitus.


FR Heller, J Jamart, P Honore, G Derue, V Novik, L … - Diabetes Care, 1993 - Am Diabetes Assoc
OBJECTIVE--To investigate subjects with different types of diabetes mellitus regarding their serum
levels of lipoprotein(a). High serum Lp(a) concentration is associated with a high risk of coronary
heart disease. Diabetic patients are prone to developing coronary heart disease. ...
Cited by 40 - Related articles - BL Direct - All 6 versions

Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects.


SM Haffner, KR Tuttle, DL Rainwater - Diabetes Care, 1991 - Am Diabetes Assoc
OBJECTIVE: Recently, lipoprotein(a) [Lp(a)] has been identified as a major risk factor for coronary
heart disease. There are few data available on the influence of metabolic control on plasma
Lp(a) concentrations in subjects with insulin-dependent diabetes mellitus (IDDM), a group ...
Cited by 60 - Related articles - All 7 versions

Lp (a) concentrations in NIDDM.


SM Haffner, PA Morales, MP Stern, MK Gruber - Diabetes, 1992 - Am Diabetes Assoc
NIDDM patients have a two- to fourfold increased risk of CHD relative to nondiabetic
subjects. This excess risk is explained only partially by increased levels of standard risk
factors. We compared the plasma concentrations of Lp(a) in NIDDM patients (n = 260) ...
Cited by 61 - Related articles - BL Direct - All 4 versions

Lipoprotein (a) in diabetic patients and normoglycemic relatives in familial NIDDM.


G Velho, D Erlich, E Turpin, D Néel, D Cohen, P … - Diabetes Care, 1993 - Am Diabetes Assoc
OBJECTIVE--To compare lipoprotein(a) levels in diabetic patients and normoglycemic relatives
in familial NIDDM and to assess whether Lp(a) is a risk factor for myocardial infarction in this
population. RESEARCH DESIGN AND METHODS--We compared 577 patients and 261 ...
Cited by 33 - Related articles - BL Direct - All 5 versions

Serum Lp (a) lipoprotein concentrations in insulin dependent diabetic patients with …

- nih.gov [PDF] 
H Kapelrud, HJ Bangstad, K Dahl-Jorgensen, K Berg, … - British Medical Journal, 1991 - bmj.com
23 Hallidas JL. An inquiry into the relationship between housing conditions and the incidence
and fatalttv ofmeasles. London: Medical Research Council, 1928. (MRC Special Report Series
No 120.) 24 Gunawardena KA, Houston K, Smith AP. Evaluation of the turbine pocket ...
Cited by 70 - Related articles - All 6 versions

Lack of change of lipoprotein (a) concentration with improved glycemic control in …


SM Haffner, KR Tuttle, DL Rainwater - Metabolism, 1992 - Elsevier
Recently, lipoprotein (a) [Lp(a)] has been identified as a major risk factor for coronary heart
disease. No data are available on the effect of improved metabolic control on plasma Lp(a) concentrations
in subjects with type II diabetes mellitus, a group at high risk for coronary heart disease. ...
Cited by 47 - Related articles - All 4 versions

Improved blood glucose control by insulin therapy in type 2 diabetic patients has …


BHR Wolffenbuttel, PB Leurs, J Sels, G … - DIABETIC …, 1993 - interscience.wiley.com
The effects of improved blood glucose control by insulin therapy on lipoprotein(a) and other lipoproteins
were studied in 54 patients with Type 2 diabetes (mean ± SD: age 67 ± 9 years, body mass index
26.1 ± 4.4 kg m −2 , median duration of diabetes 10 (range 1–37) years, 23 males, 31 ...
Cited by 23 - Related articles - BL Direct - All 4 versions

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus


A Csaszar, H Dieplinger, C Sandholzer, I Karadi, E … - Diabetologia, 1993 - Springer
Summary. Patients with Type i (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes
mellitus are at in- creased risk of developing atherosclerotic vascular diseases. A variety of lipoprotein
abnormalities have been described as being associated with this increased risk. In this ...
Cited by 52 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google